Jeff Macdonald | Investor Relations |
Mark Velleca | Chief Executive Officer |
Jack Bailey | Incoming CEO |
Soma Gupta | Chief Commercial Officer |
Raj Malik | Chief Medical Officer and Senior Vice President-Research and Development |
Jen Moses | Chief Financial Officer |
Anupam Rama | JPMorgan |
Phil Nadeau | Cowen & Co |
Tom Shrader | BTIG |
David Nierengarten | Wedbush Securities |
Gil Blum | Needham |
Tony Butler | ROTH Capital |
Ladies and gentlemen, thank you for standing by, and welcome to the G1 Therapeutics 3Q 2020 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]. I would now like to hand the conference over to your first speaker for today, the Head of Investor Relations, Mr.